COPD inhaled triple therapy (BDP/FF/G) improved symptoms, lung function, adherence, and QOL in patients previously treated with inhaled dual therapy.
Registry analysis suggests endoscopic lung volume reduction yields similar physiologic gains across sexes, but women report ...
A new study shows LA wildfires caused hidden health problems, including heart attacks and lung illness, weeks after fires ...
Background Axial spondyloarthritis (axSpA) impairs trunk strength, mobility and cardiorespiratory fitness. Despite exercise ...
In 2025, the medtech industry saw another year full of all kinds of deals in the mergers and acquisitions (M&A) arena.
Objective Patients with atrial fibrillation (AF) frequently have multiple comorbidities that increase the risk of hospitalisation and contribute to higher mortality. However, studies examining the ...
Many veterans worked in places where asbestos was normal, such as shipyards, engine rooms, boiler rooms, hangars, motor pools ...
Amazon S3 on MSN
How doctors test for healthy lung function and capacity
'Robbing them': Treasury slams states over Trump tax cuts Experts warn the internet will go down in a big way — and you'd ...
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...
In 2025, respiratory news highlighted advances in lung imaging, expanded support for pulmonary rehabilitation and promising ...
The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback